Infusion centers are under increasing pressure from payers. In 2026, a stricter authorization policy is enforced; infusions are now reviewed in greater detail with an unpredictable timeline of turnaround time. Therefore, delays affect drug delivery, chair utilization, and ultimately the outcome of the patient. Updates in the 2026 CMS Physician Fee Schedule further impact how infusion oversight, reimbursement, and documentation are evaluated.
For many, infusion center prior authorizations are causing bottlenecks when accessing infusion centres. Fast-tracking approvals requires comprehensive workflows, strong documentation, and proactive monitoring of submissions. Small adjustments create a significant impact on the approval process.
Reasons Why Infusion Authorizations Have Extended Turnaround Times
Infusions are complex and high-cost therapies that require lengthy authorizations and continuous monitoring from payers. Most infusion medications require preauthorization coupled with an initial request for approval. Common challenges include:
- Extensive authorizations for specialty medications.
- Step therapy requirements.
- Very short approval periods.
- Frequent requests for an update on clinical notes.
Once an infusion therapy is initiated, it should have a pre-authorization should be submitted. Time is essential in determining infusion treatments. If the drug is not ordered or received prior to dispensing the medication, this could result in a treatment delay.
Best Practices for Timely Treatment/Authorization
- Start the authorization process once the infusion therapy has commenced.
- Note the drugs on your preauthorization submission if the payer has a history of delaying approvals.
- Prioritize the infusion therapies in which time is of the essence.
- Inform patients regarding the anticipated timelines as close to the time of making a request as possible.
Submitting the authorization early allows additional time to work with the payer should issues arise prior to the infusion date.
Minimize the Likelihood of Coding and Drug Errors
Small mistakes can lead to denials of claims. This is especially true in infusion center billing, where accurate coding and documentation directly impact reimbursement. The name of the drug, the correct dose, and frequency must match the documentation. To avoid making an incorrect claim, ensure that:
- You have verified the HCPCS and NDC numbers
- You confirmed the number of units and route of administration
- You have matched orders with notes from the physician and nursing staff
- You have reviewed the payer’s policy regarding drug coverage
Doing it right during the initial phase will save you time during the review process.
Preparing for Post-Infusion Audits
Receiving approval does not ensure payment. The prevalence of post-service audits in the infusion industry is increasing. Audit readiness includes:
- Securely storing authorization approval records
- Matching the services billed against the authorizations for those services
- Verifying the dates of the services
- Maintaining complete clinical documentation
Preparation leads to reimbursement protection.
How Outsourcing Can Expedite Prior Authorization for Infusion Centers
As infusion volume increases, many centers find it challenging to keep pace. Outsourcing prior authorization services for infusion center treatments will:
- Provide dedicated infusion authorization expertise
- Offer quicker payer follow-ups
- Provide a consistent method for tracking requests for prior authorizations and for producing reports
- Reduce the amount of internal company workload.
Outsourcing to RCM Workshop provides speed and reliability for infusion centers that have high volumes of services. By beginning the process as soon as possible, improving documentation, tracking weekly requests, and working closely with the infusion center’s operational team, clinics can expedite infusion PA services and, ultimately, improve the overall patient experience.
